Global Ovarian Cancer Diagnostics and Therapeutics Market Report 2017: By Type & Geography - Research and Markets

DUBLIN--()--The "Global Ovarian Cancer Diagnostics and therapeutics market - segmented by type of cancer and geography (2016 - 2021)" report has been added to Research and Markets' offering.

The global market for ovarian cancer diagnostics and therapeutics accounted for USD 1,106 million in 2015 and is anticipated to grow at a CAGR of 10-16% till 2020.

Ovarian cancer is caused by an uncontrollable cell growth in the ovarian tissue. It is a growing concern, as it is one of the most common causes of death in women across the globe. Thereby, the need to develop new medication and therapies for the effective treatment of this disease, and new methods for the timely diagnosis of ovarian cancer is increasing. Thus the market for ovarian cancer diagnostics and therapeutics is at a stage of huge development.

North America dominates the global market for ovarian cancer diagnostics and therapeutics. Europe is the second largest market, after North America. Asia-Pacific is expected to show high growth rates in the next few years in this market due to large number of aging population and high prevalence of ovarian cancer. China and India are expected to be the fastest growing ovarian cancer markets in the Asia-Pacific region.

Drivers:

  • Increasing incidences of ovarian cancer worldwide
  • Increasing population of aged women
  • Greater use of combination therapies for the treatment
  • Increase in healthcare expenditure
  • Increased government funding
  • Increasing healthcare awareness

Restraints:

  • Launch of generic drugs
  • Patent expiry of key drugs
  • Lack of accurate diagnosis of ovarian cancer

Companies Mentioned:

  • Bristol Myers Squibb Company
  • Eli Lilly and Company
  • GlaxoSmithKline Plc
  • Janssen Pharmaceuticals
  • Genentech Inc.
  • Astra Zeneca
  • Boehringer Ingelheim GmbH
  • Hoffmann La Roche Ltd.

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Market Overview

4. Porters Five Force Analysis

5. Market Segmentation

6. Competitive Landscape

7. Company Profiles

8. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/hrspzc/global_ovarian

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diagnostics, Ovarian Cancer Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diagnostics, Ovarian Cancer Drugs